TCL Archive ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies June 30, 2006
TCL Archive Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin January 16, 2009
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive In Brief: NCI Ponders How Extra $40 Million Will Be Spent, Will Submit Plans to NCAB At Upcoming Meeting January 14, 1983
TCL Archive NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year January 11, 1991
